# Peter Martin

> Peter Martin is the co-founder, President and CEO of Siesta Medical, a Los Gatos medical device company building minimally invasive treatments for obstructive sleep apnea that need no masks and no machines. Since 2009 he has guided the company from an idea to FDA-cleared products - the Encore System, the Revolution Suture Passer and the AIRLIFT hyoid suspension procedure - that reposition the airway with two small implants and a stitch. A Duke and Stanford trained mechanical engineer, he spent 15-plus years in medical device operations before turning Siesta into one of the most-cited names in surgical sleep apnea care.

- **Role:** Co-founder, President and CEO at Siesta Medical, Inc.
- **Organizations:** Siesta Medical, Inc., Paracor Medical, Coalescent Surgical, W.L. Gore, Prograft Medical
- **Nationality:** American
- **Education:** BSME (Mechanical Engineering), Duke University, MSMSE (Manufacturing Systems Engineering / Mechanical), Stanford University
- **Known for:** Co-founded and leads Siesta Medical, securing multiple FDA 510(k) clearances, Brought the AIRLIFT hyoid suspension procedure to market - a mask-free, machine-free OSA treatment, Developed the Encore System and Revolution Suture Passer for hyoid and tongue suspension

## Career timeline

- **pre-2009** — Operations management roles at W.L. Gore and Prograft Medical
- **pre-2009** — VP of Operations and Quality Assurance at Coalescent Surgical (acquired by Medtronic)
- **pre-2009** — CTO, VP of R&D and Operations at Paracor Medical
- **2009** — Co-founds Siesta Medical in Los Gatos, California, with Erik van der Burg, Chris Feezor and Michael Kolber
- **2011** — Siesta Medical receives FDA 510(k) clearance for the Encore System
- **2012** — CE Mark granted; U.S. clinical study launched
- **2014** — Encore System cleared for hyoid suspension to treat obstructive sleep apnea
- **2019** — Expanded 510(k) clearance
- **2021** — Multicenter study demonstrates broad efficacy of the approach
- **2025** — International Surgical Sleep Society endorses hyoid suspension as effective and non-investigational

## Achievements

- Co-founded and leads Siesta Medical, securing multiple FDA 510(k) clearances
- Brought the AIRLIFT hyoid suspension procedure to market - a mask-free, machine-free OSA treatment
- Developed the Encore System and Revolution Suture Passer for hyoid and tongue suspension
- Clinical data showing a median 74% improvement in obstructions for AIRLIFT as part of multilevel treatment
- Helped earn 2025 endorsement of hyoid suspension from the International Surgical Sleep Society

## Latest updates

- **2025-05** — International Surgical Sleep Society endorsed hyoid myotomy/suspension as effective and non-investigational; Martin reaffirmed AIRLIFT as an alternative for patients who failed CPAP.

## Links

- Website: https://siestamedical.com
- LinkedIn: http://www.linkedin.com/in/peter-martin-0a82806
- YouTube: https://www.youtube.com/watch?v=jk7wQ-TRhxI
- Facebook: https://www.facebook.com/Siestamedicalsleep/

---

Profile page: https://yespress.io/peter-martin
Published by YesPress — https://yespress.io
Last updated: 2026-06-08